Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1376PDF: 640HTML: 292 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4648PDF: 1851HTML: 1136 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9628PDF: 6358HTML: 88344Fig.1b: 307Fig.1c: 306Fig.2a: 307Fig.2b: 276Fig.4: 333Fig.2c: 294Fig.3: 291Tab.1: 355Tab.2: 320Tab.3: 320Tab.4: 362Fig1a: 304 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3451PDF: 1137HTML: 2608 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2774PDF: 1762HTML: 2471Table1: 303 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3541PDF: 1100HTML: 3196flowcytometric result of peripheral blood sample: 285 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2523PDF: 1953HTML: 1095 -
DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION
1719PDF: 1009HTML: 2267Response to reviewers comments: 241 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1597PDF: 655HTML: 259 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
2050PDF: 918HTML: 10378Figures 1,2,3: 330 -
NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?
3465PDF: 1812HTML: 1194 -
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
301PDF: 324HTML: 66 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3993PDF: 1349HTML: 5105Incidence age-standardized rates for HL across the Mediterranean basin: 270 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4745PDF: 1836HTML: 1410 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3647PDF: 896HTML: 3043Figure 1a and 1b: 222Figure 2: 234Figure 3: 225Figure 4: 219Figure 5: 209Tables 1-5: 191 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2549PDF: 938HTML: 2325New table Chinese children with APL: 216 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1336PDF: 965HTML: 378 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1370PDF: 724HTML: 7822 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3690PDF: 2391HTML: 23673Untitled: 343Untitled: 305Untitled: 323 -
FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.
3474PDF: 1376HTML: 2380 -
-
Postpandemic influenza A/H1N1pdm09 is still causing severe perinatal complications
1701PDF: 1065HTML: 2055Cover letter: 278 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1297PDF: 833HTML: 1557Figure 1: 287Figure 2: 308 -
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3870PDF: 2674HTML: 1718







